Renal Nerve-Mediated Erythropoietin Release Confers Cardioprotection During Remote Ischemic Preconditioning.
Project/Area Number |
25861739
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Emergency medicine
|
Research Institution | Kurume University |
Principal Investigator |
OBA TOYOHARU 久留米大学, 医学部, 助教 (10389257)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | サイトカイン / 心筋保護 / プレコンディショニング / 臓器連関 / β2刺激 / シグナル伝達 |
Outline of Final Research Achievements |
Screened circulating cardioprotective JAK-STAT-activating cytokines in mice unexpectedly revealed increased serum erythropoietin (EPO) levels after formoteol injection. In mice, RIPC rapidly upregulated EPO mRNA and its main transcriptional factor, hypoxia-inducible factor-1α (HIF1α), in the kidney. Formoteol activated cardio-protective signaling pathways such as STAT3, AKT, ERK in mice heart, and reduced infarct size calculated by Evans-blue TTC staining. These results suggest that the activation of the HIF1α-EPO course in the kidney might bring reduction of the myocardial infarct size after the Formoteol dosage.
|
Report
(3 results)
Research Products
(9 results)
-
[Journal Article] Renal Nerve-Mediated Erythropoietin Release Confers Cardioprotection During Remote Ischemic Preconditioning.2015
Author(s)
Oba T, Yasukawa H, Nagata T, Kyogoku S, Minami T, Nishihara M, Ohshima H, Mawatari K, Nohara S, Takahashi J, Sugi Y, Igata S, Iwamoto Y, Kai H, Matsuoka H, Takano M, Aoki H, Fukumoto Y, Imaizumi T.
-
Journal Title
Circulation journal
Volume: ahead of print
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Cardiac-Specific SOCS3 Deletion Prevents in vivo myocardial ischemia reperfusion injury through sustained activation of cardioprotective signaling Molecules.2015
Author(s)
Nagata T, Yasukawa H, Kyogoku S, Oba T, Takahashi J, Nohara S, Minami T, Mawatari K, Sugi Y, Shimozono K, Pradervand S, Hoshijima M, Aoki H, Fukumoto Y, Imaizumi T.
-
Journal Title
PLOS ONE
Volume: in press
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms.2014
Author(s)
Kataoka Y, Shibata R, Ohashi K, Kambara T, Enomoto T, Uemura Y, Ogura Y, Yuasa D, Matsuo K, Nagata T, Oba T, Yasukawa H, Numaguchi Y, Sone T, Murohara T, Ouchi N.
-
Journal Title
J Am Coll Cardiol
Volume: 63
Issue: 24
Pages: 2722-2733
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
[Journal Article] Respiratory variation of vertebral arterial flow in a patient scheduled for coronary artery bypass graft surgery: lesson from atypical subclavian steal phenomenon2013
Author(s)
Anegawa T, Kai H, Fukuda K, Iwamoto Y, Tsuru T, Koiwaya H, Takeuchi T, Toyama Y, Oba T, Mawatari K, Takeuchi Y, Morioka M, Tanaka H, Ueno T, Imaizumi T
-
Journal Title
Circ J
Volume: 77(9)
Pages: 2412-2414
Related Report
Peer Reviewed
-
[Journal Article] Screening for Fabry disease in patients with left ventricular hypertrophy2013
Author(s)
Mawatari K, Yasukawa H, Oba T, Nagata T, Togawa T, Tsukimura T, Kyogoku S, Ohshima H, Minami T, Sugi Y, Sakuraba H, Imaizumi T
-
Journal Title
Int J Cardiol
Volume: 167(3)
Pages: 1059-1061
Related Report
Peer Reviewed
-
[Presentation] Screening for Fabry disease in patients with left ventricular hypertrophy.2014
Author(s)
Mawatari K, Yasukawa H, Oba T, Nagata T, Togawa T, Tsukimura T, Kyogoku S, Ohshima H, Minami T, Sugi Y, Imaizumi T.
Organizer
第17回日本心不全学会学術集会
Place of Presentation
さいたま
Year and Date
2014-11-28 – 2014-11-30
Related Report
-